Target
Receptor-type tyrosine-protein kinase FLT3
Ligand
BDBM50055497
Substrate
n/a
Meas. Tech.
ChEMBL_1451318 (CHEMBL3363337)
IC50
3.0±n/a nM
Citation
 Zhang, WDeRyckere, DHunter, DLiu, JStashko, MAMinson, KACummings, CTLee, MGlaros, TGNewton, DLSather, SZhang, DKireev, DJanzen, WPEarp, HSGraham, DKFrye, SVWang, X UNC2025, a potent and orally bioavailable MER/FLT3 dual inhibitor. J Med Chem 57:7031-41 (2014) [PubMed]  Article 
Target
Name:
Receptor-type tyrosine-protein kinase FLT3
Synonyms:
CD135 | CD_antigen: CD135 | FL cytokine receptor | FLK-2 | FLK2 | FLT-3 | FLT3 | FLT3_HUMAN | Fetal liver kinase-2 | Fms-like tyrosine kinase 3 | Fms-like tyrosine kinase 3 (Flt-3) | Fms-related tyrosine kinase 3 | STK-1 | STK1 | Stem cell tyrosine kinase 1
Type:
Enzyme
Mol. Mass.:
112888.62
Organism:
Homo sapiens (Human)
Description:
P36888
Residue:
993
Sequence:
MPALARDGGQLPLLVVFSAMIFGTITNQDLPVIKCVLINHKNNDSSVGKSSSYPMVSESPEDLGCALRPQSSGTVYEAAAVEVDVSASITLQVLVDAPGNISCLWVFKHSSLNCQPHFDLQNRGVVSMVILKMTETQAGEYLLFIQSEATNYTILFTVSIRNTLLYTLRRPYFRKMENQDALVCISESVPEPIVEWVLCDSQGESCKEESPAVVKKEEKVLHELFGTDIRCCARNELGRECTRLFTIDLNQTPQTTLPQLFLKVGEPLWIRCKAVHVNHGFGLTWELENKALEEGNYFEMSTYSTNRTMIRILFAFVSSVARNDTGYYTCSSSKHPSQSALVTIVEKGFINATNSSEDYEIDQYEEFCFSVRFKAYPQIRCTWTFSRKSFPCEQKGLDNGYSISKFCNHKHQPGEYIFHAENDDAQFTKMFTLNIRRKPQVLAEASASQASCFSDGYPLPSWTWKKCSDKSPNCTEEITEGVWNRKANRKVFGQWVSSSTLNMSEAIKGFLVKCCAYNSLGTSCETILLNSPGPFPFIQDNISFYATIGVCLLFIVVLTLLICHKYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFHRTWTEIFKEHNFSFYPTFQSHPNSSMPGSREVQIHPDSDQISGLHGNSFHSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMYQNVDGRVSECPHTYQNRRPFSREMDLGLLSPQAQVEDS
  
Inhibitor
Name:
BDBM50055497
Synonyms:
CHEMBL3326005
Type:
Small organic molecule
Emp. Form.:
C28H37FN6O3S
Mol. Mass.:
556.695
SMILES:
CN1CCN(CC1)S(=O)(=O)c1ccc(-c2cn([C@H]3CC[C@H](O)CC3)c3nc(NCCC4CC4)ncc23)c(F)c1 |r,wU:17.17,wD:20.21,(16.24,-.82,;14.73,-1.12,;14.23,-2.57,;12.73,-2.87,;11.72,-1.71,;12.2,-.26,;13.72,.04,;10.21,-2.01,;8.72,-1.61,;9.81,-.52,;9.73,-3.48,;10.75,-4.63,;10.28,-6.08,;8.77,-6.4,;8.29,-7.87,;9.2,-9.12,;8.29,-10.37,;8.77,-11.84,;10.27,-12.16,;10.74,-13.63,;9.71,-14.77,;10.18,-16.24,;8.2,-14.44,;7.73,-12.99,;6.82,-9.89,;5.48,-10.66,;4.15,-9.89,;2.82,-10.66,;1.49,-9.89,;.15,-10.66,;-1.18,-9.89,;-1.95,-8.55,;-2.72,-9.89,;4.15,-8.35,;5.48,-7.58,;6.82,-8.34,;7.74,-5.26,;6.24,-5.58,;8.22,-3.8,)|
Structure:
Search PDB for entries with ligand similarity: